Anti-EGFR Antibody Inhibits Proliferation of TSC2−/− Smooth Muscle Cells
Author Information
Author(s): Lesma Elena, Grande Vera, Ancona Silvia, Carelli Stephana, Di Giulio Anna Maria, Gorio Alfredo
Primary Institution: University of Milan, Milan, Italy
Hypothesis
The EGF requirement for TSC2−/− ASM cell proliferation is dependent upon the lack of tuberin.
Conclusion
The anti-EGFR antibody was more effective than rapamycin in reducing the proliferation rate of TSC2−/− ASM cells.
Supporting Evidence
- EGF is a proliferative factor for TSC2−/− ASM cells.
- Anti-EGFR antibodies significantly inhibited the proliferation of TSC2−/− ASM cells.
- Rapamycin reduced proliferation but was less effective than anti-EGFR antibodies.
- TSC2 transfection altered the dependency on EGF for cell growth.
- Phosphorylation of S6 and ERK was affected by anti-EGFR treatment.
Takeaway
This study found that a specific antibody can stop certain cells from growing because they lack a protein that usually helps control their growth.
Methodology
The study evaluated the effects of EGF and anti-EGFR antibodies on the proliferation of TSC2−/− ASM cells and analyzed phosphorylation levels of various proteins.
Limitations
The study primarily focused on in vitro experiments, which may not fully replicate in vivo conditions.
Participant Demographics
Cells were isolated from a 42-year-old female TSC2 patient.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website